ING Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-76,800
Closed -$1.25M 566
2024
Q1
$1.25M Buy
76,800
+5,500
+8% +$86K 0.01% 496
2023
Q4
$1.06M Buy
+71,300
New +$808K 0.01% 478
2023
Q1
Sell
-600,000
Closed -$7.33M 670
2022
Q4
$7.33M Buy
+600,000
New +$7.48M 0.07% 186
2021
Q3
Sell
-275,000
Closed -$9.54M 603
2021
Q2
$9.54M Buy
+275,000
New +$9.07M 0.15% 101
2020
Q3
Sell
-432,199
Closed -$9.27M 481
2020
Q2
$9.27M Buy
+432,199
New +$9.55M 0.4% 35

Other funds holding ELAN

ING Group's ELAN Position: Q2 2024 in Review

ING Group sold out of Elanco Animal Health (ELAN) in Q2 2024, closing a stake of 76,800 shares — an estimated $1.25M sold.

ING Group first reported a position in ELAN in Q2 2020 and held it in 5 quarters. The position peaked at $9.54M in Q2 2021. 402 funds tracked by Wall St. Rank hold ELAN as of Q2 2024.

  • ING Group reported no remaining Elanco Animal Health position as of Q2 2024 after selling out during the quarter.
  • ING Group sold 76,800 Elanco Animal Health shares in Q2 2024, an estimated $1.25M.
  • ING Group first reported a position in Elanco Animal Health in Q2 2020 and held it in 5 quarters.
  • ING Group's Elanco Animal Health position peaked at $9.54M in Q2 2021.
  • 402 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2024.

Based on ING Group's 13F filing for Q2 2024, filed 13 Aug 2024.